Literature DB >> 10200318

Genetic background changes the pattern of forebrain commissure defects in transgenic mice underexpressing the beta-amyloid-precursor protein.

F Magara1, U Müller, Z W Li, H P Lipp, C Weissmann, M Stagljar, D P Wolfer.   

Abstract

We previously have reported corpus callosum defects in transgenic mice expressing the beta-amyloid precursor protein (betaAPP) with a deletion of exon 2 and at only 5% of normal levels. This finding indicates a possible involvement of betaAPP in the regulation or guidance of axon growth during neural development. To determine to what degree the betaAPP mutation interacts with genetic background alleles that predispose for forebrain commissure defects in some mouse lines, we have assessed the size of the forebrain commissures in a sample of 298 mice. Lines with mixed genetic background were compared with congenic lines obtained by backcrossing to the parental strains C57BL/6 and 129/SvEv. Mice bearing a null mutation of the betaAPP gene also were included in the analysis. We show that, independently of genetic background, both lack and underexpression of betaAPP are associated with reduced brain weight and reduced size of forebrain commissures, especially of the ventral hippocampal commissure. In addition, both mutations drastically increase the frequency and severity of callosal agenesis and hippocampal commissure defects in mouse lines with 129/SvEv or 129/Ola background.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10200318      PMCID: PMC16388          DOI: 10.1073/pnas.96.8.4656

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  A rapid, sensitive histochemical stain for myelin in frozen brain sections.

Authors:  L C Schmued
Journal:  J Histochem Cytochem       Date:  1990-05       Impact factor: 2.479

2.  Hypersensitivity to seizures in beta-amyloid precursor protein deficient mice.

Authors:  J P Steinbach; U Müller; M Leist; Z W Li; P Nicotera; A Aguzzi
Journal:  Cell Death Differ       Date:  1998-10       Impact factor: 15.828

Review 3.  Genetic and developmental defects of the mouse corpus callosum.

Authors:  D Wahlsten
Journal:  Experientia       Date:  1989-09-15

4.  Deficient corpus callosum in hybrids between ddN and three other abnormal mouse strains.

Authors:  D Wahlsten; H S Ozaki; D Livy
Journal:  Neurosci Lett       Date:  1992-02-17       Impact factor: 3.046

5.  Deficiency of the corpus callosum: incomplete penetrance and substrain differentiation in BALB/c mice.

Authors:  D Wahlsten
Journal:  J Neurogenet       Date:  1989-01       Impact factor: 1.250

6.  Tests of genetic allelism between four inbred mouse strains with absent corpus callosum.

Authors:  D J Livy; D Wahlsten
Journal:  J Hered       Date:  1991 Nov-Dec       Impact factor: 2.645

7.  Mice in utero while their mother is lactating suffer higher frequency of deficient corpus callosum.

Authors:  D Wahlsten
Journal:  Brain Res       Date:  1982-11       Impact factor: 3.252

8.  Inheritance of retarded forebrain commissure development in fetal mice: results from classical crosses and recombinant inbred strains.

Authors:  D Wahlsten; G Smith
Journal:  J Hered       Date:  1989 Jan-Feb       Impact factor: 2.645

9.  Prenatal formation of the normal mouse corpus callosum: a quantitative study with carbocyanine dyes.

Authors:  H S Ozaki; D Wahlsten
Journal:  J Comp Neurol       Date:  1992-09-01       Impact factor: 3.215

10.  The fibers which course within the Probst's longitudinal bundle seen in the brain of a congenitally acallosal mouse: a study with the horseradish peroxidase technique.

Authors:  H S Ozaki; M Shimada
Journal:  Brain Res       Date:  1988-02-16       Impact factor: 3.252

View more
  53 in total

Review 1.  Functions of the APP gene family in the nervous system: insights from mouse models.

Authors:  Dorothee Aydin; Sascha W Weyer; Ulrike C Müller
Journal:  Exp Brain Res       Date:  2011-09-20       Impact factor: 1.972

2.  Deficits in axonal transport in hippocampal-based circuitry and the visual pathway in APP knock-out animals witnessed by manganese enhanced MRI.

Authors:  Joseph J Gallagher; Xiaowei Zhang; Gregory J Ziomek; Russell E Jacobs; Elaine L Bearer
Journal:  Neuroimage       Date:  2012-02-10       Impact factor: 6.556

Review 3.  Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.

Authors:  Meaghan C Creed; Norton W Milgram
Journal:  Age (Dordr)       Date:  2010-04-20

4.  Hippocampal commissure defects in crosses of four inbred mouse strains with absent corpus callosum.

Authors:  M O Bohlen; J D Bailoo; R L Jordan; D Wahlsten
Journal:  Genes Brain Behav       Date:  2012-05-30       Impact factor: 3.449

5.  Neuronal untranslated BC1 RNA: targeted gene elimination in mice.

Authors:  Boris V Skryabin; Valentina Sukonina; Ursula Jordan; Lars Lewejohann; Norbert Sachser; Ilham Muslimov; Henri Tiedge; Jürgen Brosius
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

6.  Growth-associated protein-43 is required for commissural axon guidance in the developing vertebrate nervous system.

Authors:  Yiping Shen; Shyamala Mani; Stacy L Donovan; James E Schwob; Karina F Meiri
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

7.  The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.

Authors:  Stephanie J Soscia; James E Kirby; Kevin J Washicosky; Stephanie M Tucker; Martin Ingelsson; Bradley Hyman; Mark A Burton; Lee E Goldstein; Scott Duong; Rudolph E Tanzi; Robert D Moir
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

Review 8.  Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system.

Authors:  Collin Y Ewald; Chris Li
Journal:  Brain Struct Funct       Date:  2009-12-11       Impact factor: 3.270

9.  Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members.

Authors:  Jochen Herms; Brigitte Anliker; Sabine Heber; Sabine Ring; Martin Fuhrmann; Hans Kretzschmar; Sangram Sisodia; Ulrike Müller
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

10.  COL25A1 triggers and promotes Alzheimer's disease-like pathology in vivo.

Authors:  Ying Tong; Ying Xu; Kimberly Scearce-Levie; Louis J Ptácek; Ying-Hui Fu
Journal:  Neurogenetics       Date:  2009-06-23       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.